These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 35445333)
1. Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma. Bai J; Deng C; Fu F; Li D; Ma Z; Ma X; Zhang Y; Chen H J Cancer Res Clin Oncol; 2023 Apr; 149(4):1383-1389. PubMed ID: 35445333 [TBL] [Abstract][Full Text] [Related]
2. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy. Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178 [TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328 [No Abstract] [Full Text] [Related]
4. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231 [TBL] [Abstract][Full Text] [Related]
5. Management of Ground-Glass Opacities in the Lung Cancer Spectrum. Zhang Y; Fu F; Chen H Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031 [TBL] [Abstract][Full Text] [Related]
6. A computerized tomography-based radiomic model for assessing the invasiveness of lung adenocarcinoma manifesting as ground-glass opacity nodules. Zhu M; Yang Z; Wang M; Zhao W; Zhu Q; Shi W; Yu H; Liang Z; Chen L Respir Res; 2022 Apr; 23(1):96. PubMed ID: 35429974 [TBL] [Abstract][Full Text] [Related]
7. Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity. Lu X; Chen Y; Li Y; Tang M; Zheng X Sci Rep; 2024 Jul; 14(1):15679. PubMed ID: 38977890 [TBL] [Abstract][Full Text] [Related]
8. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities. Ichinose J; Kohno T; Fujimori S; Harano T; Suzuki S; Fujii T Ann Thorac Cardiovasc Surg; 2014; 20(5):347-52. PubMed ID: 24088912 [TBL] [Abstract][Full Text] [Related]
9. The long-term course of ground-glass opacities detected on thin-section computed tomography. Lee SW; Leem CS; Kim TJ; Lee KW; Chung JH; Jheon S; Lee JH; Lee CT Respir Med; 2013 Jun; 107(6):904-10. PubMed ID: 23514949 [TBL] [Abstract][Full Text] [Related]
10. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma. Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952 [TBL] [Abstract][Full Text] [Related]
11. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267 [TBL] [Abstract][Full Text] [Related]
12. Partly solid pulmonary nodules: waiting for change or surgery outright? Seok Y; Cho S; Kim K; Jheon S Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):556-60. PubMed ID: 24981106 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity. Wang Y; Jing L; Wang G J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020 [TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: a review of 5 years' experience. Duann CW; Hung JJ; Hsu PK; Huang CS; Hsieh CC; Hsu HS; Wu YC; Hsu WH J Chin Med Assoc; 2013 Dec; 76(12):693-7. PubMed ID: 24099986 [TBL] [Abstract][Full Text] [Related]
16. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Shewale JB; Nelson DB; Rice DC; Sepesi B; Hofstetter WL; Mehran RJ; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Antonoff MB Ann Thorac Surg; 2018 Jun; 105(6):1671-1677. PubMed ID: 29432718 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of resected solitary ground-glass opacities: Comparison between benign and malignant nodules. Qin Y; Xu Y; Ma D; Tian Z; Huang C; Zhou X; He J; Liu L; Guo C; Wang G; Zhang J; Wang Y; Liu H Thorac Cancer; 2020 Oct; 11(10):2767-2774. PubMed ID: 32844603 [TBL] [Abstract][Full Text] [Related]
18. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200 [TBL] [Abstract][Full Text] [Related]
19. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected? Kobayashi Y; Mitsudomi T Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254 [TBL] [Abstract][Full Text] [Related]
20. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Mirtcheva RM; Vazquez M; Yankelevitz DF; Henschke CI Clin Imaging; 2002; 26(2):95-100. PubMed ID: 11852215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]